ANDREA SWAIN: Open Payments
NPI 1437844792 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 19 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $736 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Lilly USA, LLC | 2 | $33 |
| ABBVIE INC. | 1 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Seqirus USA Inc | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Insulet Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, CAPLYTA, AIRSUPRA, MOUNJARO, UBRELVY, TRELEGY ELLIPTA, Fluad, GEMTESA.
Industry payments across TN — which companies pay providers there.
